StockData
CorMedix Inc. logo

CorMedix Inc. (CRMD) stock

CRMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$4.50−0.17 (-3.64%)

Close on Nov 18, 2026Market cap $350.75MP/E –Yield –

CorMedix operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

CorMedix's operating income for the twelve months ending Jun 30, 2026 was $217.04M, up 340.1% year over year. For fiscal 2025 it was $150.14M. The highest annual figure on record is $150.14M in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$150.14M–
FY2024Dec 31, 2024-$22.36M–
FY2023Dec 31, 2023-$48.96M–
FY2022Dec 31, 2022-$30.62M–
FY2021Dec 31, 2021-$29.44M–
FY2020Dec 31, 2020-$27.22M–
FY2019Dec 31, 2019-$21.01M–
FY2018Dec 31, 2018-$26.86M–
FY2017Dec 31, 2017-$32.92M–
FY2016Dec 31, 2016-$24.76M–
FY2015Dec 31, 2015-$16.65M–
FY2014Dec 31, 2014-$8.90M–
FY2013Dec 31, 2013-$4.92M–
FY2012Dec 31, 2012-$3.00M–
FY2011Dec 31, 2011-$7.21M–
FY2010Dec 31, 2010-$8.51M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$42.91M+119.6%
Q1 FY2026Mar 31, 2026$63.66M+216.3%
Q4 FY2025Dec 31, 2025$59.13M+357.1%
Q3 FY2025Sep 30, 2025$51.35M–
Q2 FY2025Jun 30, 2025$19.54M–
Q1 FY2025Mar 31, 2025$20.13M–
Q4 FY2024Dec 31, 2024$12.94M–
Q3 FY2024Sep 30, 2024-$3.29M–
Q2 FY2024Jun 30, 2024-$15.30M–
Q1 FY2024Mar 31, 2024-$16.70M–
Q4 FY2023Dec 31, 2023-$15.67M–
Q3 FY2023Sep 30, 2023-$10.47M–
Q2 FY2023Jun 30, 2023-$11.80M–
Q1 FY2023Mar 31, 2023-$11.02M–
Q4 FY2022Dec 31, 2022-$8.39M–
Q3 FY2022Sep 30, 2022-$6.96M–
Q2 FY2022Jun 30, 2022-$8.24M–
Q1 FY2022Mar 31, 2022-$7.03M–
Q4 FY2021Dec 31, 2021-$7.78M–
Q3 FY2021Sep 30, 2021-$8.56M–
Q2 FY2021Jun 30, 2021-$5.88M–
Q1 FY2021Mar 31, 2021-$7.21M–
Q4 FY2020Dec 31, 2020-$6.08M–
Q3 FY2020Sep 30, 2020-$6.60M–
Q2 FY2020Jun 30, 2020-$8.92M–
Q1 FY2020Mar 31, 2020-$5.61M–
Q4 FY2019Dec 31, 2019-$5.38M-351.4%
Q3 FY2019Sep 30, 2019-$5.17M–
Q2 FY2019Jun 30, 2019-$5.54M–
Q1 FY2019Mar 31, 2019-$4.92M–
Q4 FY2018Dec 31, 2018$2.14M–
Q3 FY2018Sep 30, 2018-$10.24M–
Q2 FY2018Jun 30, 2018-$8.57M–
Q1 FY2018Mar 31, 2018-$10.19M–
Q4 FY2017Dec 31, 2017-$10.27M–
Q3 FY2017Sep 30, 2017-$8.01M–
Q2 FY2017Jun 30, 2017-$7.02M–
Q1 FY2017Mar 31, 2017-$7.62M–
Q4 FY2016Dec 31, 2016-$6.43K–
Q3 FY2016Sep 30, 2016-$9.16M–

More CorMedix figures

See a number that looks wrong?